Amicus Therapeutics (Nasdaq: FOLD) and Glaxo Group Limited (NYSE: GSK) announced an expansion of their collaboration to develop and commercialize ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE